| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 10/06/2004 | CN1169834C Process for separating megakaryocyte stimulating factor from human plasma and application |
| 10/06/2004 | CN1169824C Polytype gene of MXA protein and application thereof |
| 10/05/2004 | US6801861 Apparatus and method for automated protein design |
| 10/05/2004 | US6800794 For disease/pathogen resistance in plants, especially grapes; improved fermentation for wine without pesticides |
| 10/05/2004 | US6800791 Method for delivery of proteins to plant cells |
| 10/05/2004 | US6800790 Method for maintenance and propagation of germline stem cells using members of the TFG-β family of growth factors |
| 10/05/2004 | US6800753 Biodegradable tissue scaffolds |
| 10/05/2004 | US6800749 G-protein coupled receptor |
| 10/05/2004 | US6800740 Variants of native growth hormones having non naturally occurring amino acid sequences or covalent modifications |
| 10/05/2004 | US6800737 Amino acid sequences; anticaner agents, monitoring, diagnosis |
| 10/05/2004 | US6800735 Interferon-beta fusion proteins and uses |
| 10/05/2004 | US6800733 Genetically adjusted fluorescent protein for use as detection tool genetic engineering |
| 10/05/2004 | US6800632 Bicyclic inhibitors of glycogen synthase kinase 3 |
| 10/05/2004 | US6800604 Polypeptides that inhibit human serum-induced cleavage of hepatocyte growth factor |
| 10/05/2004 | US6800484 Transforming preferential cells; obtain cell, incubate with nucleotide sequences, expose to electrical charge, recover transformed cells |
| 10/05/2004 | US6800483 Compositions and methods for sensitizing and inhibiting growth of human tumor cells |
| 10/05/2004 | US6800482 Cultured cells of Australian laurel, Pittosporaceae and a method for culturing tissues by using said cultured cells |
| 10/05/2004 | US6800481 Stable macroscopic membranes formed by self-assembly of amphiphilic peptides and uses therefor |
| 10/05/2004 | US6800480 Methods and materials for the growth of primate-derived primordial stem cells in feeder-free culture |
| 10/05/2004 | US6800471 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 10/05/2004 | US6800470 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 10/05/2004 | US6800469 Methods for diagnosis and therapy of autoimmune disease, such as insulin dependent diabetes mellitus, involving retroviral superantigens |
| 10/05/2004 | US6800467 Useful as flavor improving agents for food products (soups, sauces, seasonings); protein hydrolysis; obtained from aspergillus, escherichia |
| 10/05/2004 | US6800465 D-hydantoinase from Ochrobactrum anthropi |
| 10/05/2004 | US6800464 Arthrobacter D-carbamoylase and methods of preparing enantiomerically enriched D-amino acids |
| 10/05/2004 | US6800461 The b-domain of the wild-type factor viii cdna has been deleted and a truncated factor ix intron 1 has been inserted in one or more locations of the factor viii cdna; vector for human gene therapy |
| 10/05/2004 | US6800456 Modified forms of hepatitis C NS3 protease for facilitating inhibitor screening and structural studies of protease:inhibitor complexes |
| 10/05/2004 | US6800447 Methods for identifying compounds which bind the active CCR5 chemokine receptor |
| 10/05/2004 | US6800445 Systems for sensitive detection of G-protein coupled receptor and orphan receptor function using reporter enzyme mutant complementation |
| 10/05/2004 | US6800442 Engineering of recombinant viruses as expression vectors for tumor, cancer, or infected cell-specific antigens; reduces the frequency of false positives of differentially expressed dna fragments; homologous recombination |
| 10/05/2004 | US6800285 Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| 10/05/2004 | US6800282 Cell culture products |
| 10/05/2004 | CA2128833C P53as protein and antibody therefor |
| 10/04/2004 | CA2462792A1 Method for synthesizing ectomycorrhiza in vitro |
| 10/04/2004 | CA2462743A1 Method for colonizing a plant with an ectomycorrhizal fungus |
| 10/02/2004 | CA2463443A1 Composite scaffolds seeded with mammalian cells |
| 10/02/2004 | CA2444359A1 Artificial cartilage |
| 10/01/2004 | WO2005038029A2 Luciferase biosensor |
| 10/01/2004 | CA2541765A1 Luciferase biosensor |
| 09/30/2004 | WO2004083419A1 Fructosylamine oxidase |
| 09/30/2004 | WO2004083417A1 The transformed plant cell expressing tandem repeats of beta-amyloid gene and plant produced by the same |
| 09/30/2004 | WO2004083416A1 Method of transferring cell sheet and device for transferring cell sheet |
| 09/30/2004 | WO2004083415A1 Cartilaginous cell culture medium and the use thereof |
| 09/30/2004 | WO2004083414A1 Monocyte-origin multipotent cell momc |
| 09/30/2004 | WO2004083413A1 Organ-forming method |
| 09/30/2004 | WO2004083412A1 Method of cell culturing and cell sheet |
| 09/30/2004 | WO2004083406A2 Genes that are up- or down-regulated during differentiation of human embryonic stem cells |
| 09/30/2004 | WO2004083400A2 Animal product-free cell culture media extracts, supplements and culture media supplement systems |
| 09/30/2004 | WO2004083394A2 Human g protein-coupled receptors and modulators thereof for the treatment of inflammatory disorders |
| 09/30/2004 | WO2004083392A2 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 09/30/2004 | WO2004083384A2 Accelerated culture system for intestinal epithelial cell monolayers |
| 09/30/2004 | WO2004083378A2 Mammalian cell lines specifically deficient in o-linked glycosylation |
| 09/30/2004 | WO2004083375A2 Methods of promoting the differentiation of stem cells |
| 09/30/2004 | WO2004083372A2 Modulators of the notch signaling pathway immobilized on particles for modifying immune responses |
| 09/30/2004 | WO2004083364A2 Cell preparation and use of the preparation for treating joints and cartilage defects, and methods for the production thereof |
| 09/30/2004 | WO2004082710A1 Treatment of allergic diseases using a modulator of the notch signaling pathway |
| 09/30/2004 | WO2004082640A2 Human serum albumin conjugates with therapeutic compounds |
| 09/30/2004 | WO2004082370A2 Cardiac-preferred genetic alteration of transgenic rabbits |
| 09/30/2004 | WO2004074445A9 Model for studying the role of genes in tumor resistance to chemotherapy |
| 09/30/2004 | WO2004064785A9 Cancer therapy sensitizer |
| 09/30/2004 | WO2004044146A3 Pluripotent cells from monocytes, and methods of making and using pluripotent cells |
| 09/30/2004 | WO2004042033A3 Circulating stem cells and uses related thereto |
| 09/30/2004 | WO2004037982A3 High expression locus vector based on ferritin heavy chain gene locus |
| 09/30/2004 | WO2003102021A3 Cotton rat lung cells for virus culture |
| 09/30/2004 | WO2003087333A8 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| 09/30/2004 | WO2003082200A3 Potent oncolytic herpes simplex virus for cancer therapy |
| 09/30/2004 | WO2003080105A9 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 09/30/2004 | WO2003072740A3 Novel type-1 cytokine receptor glm-r |
| 09/30/2004 | WO2003062447A3 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 09/30/2004 | WO2003052065A3 Antisense modulation of b-cell associated protein expression |
| 09/30/2004 | WO2003049703A3 Chimeric infectious dna clones, chimeric porcine circoviruses and uses thereof |
| 09/30/2004 | WO2003014323A3 Human smooth muscle myosin heavy chain |
| 09/30/2004 | US20040194164 Xenorhabdus TC proteins and genes for pest control |
| 09/30/2004 | US20040194160 Expression vector comprising nucleotide sequences coding glucocorticoid-induced leucine-zipper family related protein (GILR) and tissue specific regulatory regions for transformation and generation of animal models to identify glucocorticoid hormones regulated genes associated with apoptosis control |
| 09/30/2004 | US20040194159 Cloning pigs using donor nuclei from differentiated cells |
| 09/30/2004 | US20040194158 Model for neurodegenerative disorders |
| 09/30/2004 | US20040194155 Comprises hepatitis b viral nucleotide sequences coding mutant reverse transcriptase for use in developing antibodies to prevent or treat hepatitis viral infection; immunotherapy; |
| 09/30/2004 | US20040193284 Granulated cultrue product of Dna, endothelial growth factor; spraying through multilayer tubes with pressure valve ; interior body expandes; supplying patch; repair damage tissue |
| 09/30/2004 | US20040193274 Materials and methods for augmenting and/or repairing intervertebral discs |
| 09/30/2004 | US20040192903 Comprises chromosomal regoin which codes pathogenicity islands (PAIs) for use in developing antibodies to detect and prevent bacterial infection; bactericides |
| 09/30/2004 | US20040192899 B-7 domain-specific antibodies |
| 09/30/2004 | US20040192898 Anti-abeta antibodies |
| 09/30/2004 | US20040192892 Isolated mammalian membrane protein genes; related reagents |
| 09/30/2004 | US20040192889 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof |
| 09/30/2004 | US20040192654 use of nucleoside analogues as an effective treatment for acute or chronic myelogenous leukemia; (-)- beta -L-Dioxolane-Cytidine ( beta -L-oddC); (-)- beta -Dioxolane-5-fluoro-Cytidine (5-FddC) |
| 09/30/2004 | US20040192629 Selectively inhibit the mutant while retaining wild-type gene expression to treat diseases caused by dominant mutants such as amyotrophic lateral sclerosis, Huntington's disease, Alzheimer's disease, and Parkinson's disease; administering to the cell an siRNA specific for the target allele |
| 09/30/2004 | US20040192607 Transcriptional regulation of the human beta3-adrenergic receptor gene |
| 09/30/2004 | US20040192603 Substantially non-immunogenic injectable collagen |
| 09/30/2004 | US20040192588 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 09/30/2004 | US20040191912 New constitutive plant promoter |
| 09/30/2004 | US20040191908 Method and composition for clonal propagation of pandanus amaryllifolius |
| 09/30/2004 | US20040191907 Cultured plant tissues for use as tissue engineering transformation tools |
| 09/30/2004 | US20040191906 Using ultrasonic transducer to enhance growth of myocardium tissue, revascularization and inhibit restenosis |
| 09/30/2004 | US20040191903 Method and therapeutic platelets |
| 09/30/2004 | US20040191902 Generating hepatocyte-like cell; provide stem cells, inoculate with cytokines and hepatocyte growth factor mixture, culture and recover cells; tissue engineering |
| 09/30/2004 | US20040191901 Insulin producing cells derived from human embryonic stem cells |
| 09/30/2004 | US20040191900 Using in situ formation of cartilage layer over an articular cartilage lesion to repair injured bone tissue;tissue engineering |
| 09/30/2004 | US20040191899 Method for disrupting cells that lack a cell wall |
| 09/30/2004 | US20040191898 Trangenic diploid cell comprising mutation in kinase allele for use in screening modulator for treatment of anxiety, addiction, withdrawal syndrome, skeletal muscle spasms, convulsive seizures and epilepsy |
| 09/30/2004 | US20040191870 Methods of 6-0 sulfating polysaccharides and 6-0 sulfated polysaccharide preparations |